Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.088 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |